Characterization of human GTPBP3, a GTP-binding protein involved in mitochondrial tRNA modification

Molecular and Cellular Biology

Volumn 28, Issue 24, 2008, Pages 7514-7531

  Villarroya, Magda ^a   Prado, Silvia ^a   Esteve, Juan M ^a   Soriano, Miguel A ^a   Aguado, Carmen ^a   Pérez Martínez, David ^a,c   Martínez Ferrandis, José I ^a,d   Yim, Lucía ^a,e   Victor, Victor M ^b   Cebolla, Elvira ^a   Montaner, Asunción ^a   Knecht, Erwin ^a   Armengod, M Eugenia ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e Universidad de la Republica Instituto de Higiene   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTERIAL PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN 3; GUANOSINE TRIPHOSPHATASE; POTASSIUM; PROTEIN MNME; SMALL INTERFERING RNA; TRANSFER RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

BACTERIA (MICROORGANISMS);

EID: 57349096320     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00946-08     Document Type: Article

References (57)

1. Antonická, H., D. Floryk, P. Klement, L. Stratilova, J. Heřmanská, H. Houštková, M. Kalous, Z. Drahota, J. Zeman, and J. Houštěk. 1999. Defective kinetics of cytochrome c oxidase and alteration of mitochondrial potential in fibroblasts and cytoplasmic hybrid cells with the mutation for myoclonus epilepsy with ragged-red fibres ("MERRF") at position 8344 nt. Biochem. J. 342:537-544.
2. Beaudoing, E., S. Freier, J. R. Wyatt, J.-M. Claverie, and D. Gautheret. 2000. Patterns of variant polyadenylation signal usage in human genes. Genome Res. 10:1001-1010.
3. Björk, G. R. 1998. Modified nucleosides at positions 34 and 37 of tRNAs and their predicted coding capacities, p. 577-581. In H. Grosjean, and R. Benne, R. (ed.), Modification and editing of RNA. ASM Press, Washington, DC.
4. Björk, G. R., and T. G. Hagervall. July 2005, posting date. Chapter 4.6.2, Transfer RNA modification. In R. Curtiss III et al. (ed.), EcoSal - Escherichia coli and Salmonella: cellular and molecular biology. ASM Press, Washington, DC. http://www.ecosal.org.
5. Brégeon, D., V. Colot, M. Radman, and F. Taddei. 2001. Translational misreading: a tRNA modification counteracts a +2 ribosomal frameshift. Genes Dev. 15:2295-2306.
6. Cabedo, H., F. Macián, M. Villarroya, J. C. Escudero, M. Martínez-Vicente, E. Knecht, and M.-E. Armengod. 1999. The Escherichia coli trmE (mnmE) gene, involved in tRNA modification, codes for an evolutionarily conserved GTPase with unusual biochemical properties. EMBO J. 18:7063-7076.
7. Chua, K., and R. Reed. 2001. An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing. Mol. Cell. Biol. 21:1509-1514.
8. Colby, G., M. Wu, and A. Tzagoloff. 1998. MTO1 codes for a mitochondrial protein required for respiration in paromomycin-resistant mutants of Saccharomyces cerevisiae. J. Biol. Chem. 273:27945-27952.
9. Decoster, E., A. Vassal, and G. Faye. 1993. MSS1, a nuclear-encoded mitochondrial GTPase involved in the expression of COX1 subunit of cytochrome c oxidase. J. Mol. Biol. 232:79-88.
10. Elseviers, D., L. A. Petrullo, and P. Gallagher. 1984. Novel E. coli mutants deficient in biosynthesis of 5-methylaminomethyl-2- thiouridine. Nucleic Acids Res. 12:3521-3534.
11. Fuertes, G., J. J. Martín de Llano, A. Villarroya, A. J. Rivett, and E. Knecht. 2003. Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions. Biochem. J. 375:75-86.
12. Grisolía, S., J. Hernández-Yago, and E. Knecht. 1985. Regulation of mitochondrial protein concentration: a plausible model which may permit assessing protein turnover. Curr. Topics Cell Regul. 27:387-396.
13. Guzmán, L. M., D. Belin, M. J. Carson, and J. Beckwith. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 177:4121-4130.
14. Hagervall, T. G., C. G. Edmonds, J. A. McCloskey, and G. R. Björk. 1987. Transfer RNA (5-methylaminomethyl-2-thiouridine)- methyltransferase from Escherichia coli K-12 has two enzymatic activities. J. Biol. Chem. 262:8488-8495.
15. Ikeuchi, Y., N. Shigi, J. Kato, A. Nishimura, and T. Suzuki. 2006. Mechanistic insights into sulfur relay by multiple sulfur mediators involved in thiouridine biosynthesis at tRNA wobble positions. Mol. Cell 21:97-108.
16. James, A. M., Y.-H. Wei, C.-Y. Pang, and M. P. Murphy. 1996. Altered mitochondrial DNA mutations. Biochem. J. 318:401-407.
17. Käser, M., and T. Langer. 2000. Protein degradation in mitochondria. Semin. Cell Dev. Biol. 11:181-190.
18. Leu(CUN) bearing the G12300A mutation suppresses the MELAS molecular defect. Hum. Mol. Genet. 15:897-904.
19. Kirino, Y., T. Yasukawa, S. Ohta, S. Akira, K. Ishihara, K. Watanabe, and T. Suzuki. 2004. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc. Natl. Acad. Sci. USA 101:15070-15075.
20. Kirino, Y., Y. Goto, Y. Campos, J. Arenas, and T. Suzuki. 2005. Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease. Proc. Natl. Acad. Sci. USA 102:7127-7132.
21. Knecht, E., J. Hernández-Yago, A. Martínez-Ramón, and S. Grisolía. 1980. Fate of proteins synthesized in mitochondria of cultured mammalian cells revealed by electron microscope radioautography. Exp. Cell Res. 125:191-199.
22. Koopen, M., and T. Langer. 2007. Protein degradation within mitochondria: versatile activities of AAA proteases and other peptidases. Mol. Biol. 42:221-242.
23. Li, X., and M.-X. Guan. 2002. A human mitochondrial GTP binding protein related to tRNA modification may modulate phenotypic expression of the deafness-associated mitochondrial 12S rRNA mutation. Mol. Cell. Biol. 22:7701-7711.
24. Li, X., and M.-X. Guan. 2003. Identification and characterization of mouse GTPBP3 gene encoding a mitochondrial GTP-binding protein involved in tRNA modification. Biochem. Biophys. Res. Commun. 312:747-754.
25. Li, X., R. Li, X. Lin, and M.-X. Guan. 2002. Isolation and characterization of the putative nuclear modifier gene MTO1 involved in the pathogenesis of deafness-associated mitochondrial 12 S rRNA A1555G mutation. J. Biol. Chem. 277:27256-27264.
26. Lim, K., J. H. Ho, K. Keeling, G. L. Gilliland, X. Ji, F. Rüker, and D. C. Carter. 1994. Three-dimensional structure of Schistosoma japonicum glutathione S-transferase fused with a six-amino acid conserved neutralizing epitope of gp41 from HIV. Protein Sci. 3:2233-2244.
27. Martínez-Vicente, M., L. Yim, M. Villarroya, M. Mellado, E. Pérez-Payá, G. R. Björk, and M.-E. Armengod. 2005. Effects of mutagenesis in the switch I region and conserved arginines of Escherichia coli MnmE protein, a GTPase involved in tRNA modification. J. Biol. Chem. 280:30660-30670.
28. Meyer, S., A. Scrima, W. Versées, and A. Wittinghofer. 2008. Crystal structures of the conserved tRNA modifying enzyme GidA: implications for its interaction with MnmE and substrate. J. Mol. Biol. 380:532-547.
29. Miller, J. H. 1992. A short course in bacterial genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. Norton, P. A. 1994. Polypyrimidine tract sequences direct selection of alternative branch sites and influence protein binding. Nucleic Acids Res. 22:3854-3860.
31. Nuñez, C., V. M. Víctor, R. Tur, A. Alvarez-Barrientos, S. Moncada, J. Esplugues, and P. D'Ocon. 2005. Discrepancies between nitroglycerin and NO-releasing drugs on mitochondrial oxygen consumption, vasoactivity, and the release of NO. Circ. Res. 97:1063-1069.
32. Nurtdinov, R. M., I. I. Artamonova, A. A. Mironov, and M. S. Gelfand. 2003. Low conservation of the alternative splicing patterns in the human and mouse genomes. Hum. Mol. Genet. 12:1313-1320.
33. Pang, C.-Y., H.-C. Lee, and Y.-H. Wei. 2001. Enhanced oxidative damage in human cells harbouring A3243G mutation of mitochondrial DNA: implication of oxidative stress in the pathogenesis of mitochondrial diabetes. Diabetes Res. Clin. Pract. 54(Suppl. 2):S45-S56.
34. Reed, R. 1989. The organization of 3′ splice-site sequences in mammalian introns. Genes Dev. 3:2113-2123.
35. Roscigno, R. F., M. Weiner, and M. A. García-Blanco. 1993. A mutational analysis of the polypyrimidine tract of introns. Effects of sequence differences in pyrimidine tracts on splicing. J. Biol. Chem. 268:11222-11229.
36. Ruiz-Pesini, E., and D. C. Wallace. 2006. Evidence for adaptive selection acting on the tRNA and rRNA genes of human mitochondrial DNA. Hum. Mutat. 27:1072-1081.
37. Schon, E. A., E. Bonilla, and S. DiMauro. 1997. Mitochondrial DNA mutations and pathogenesis. J. Bioenerg. Biomembr. 29:131-149.
38. ras and other GTP-binding proteins. Nat. Struct. Biol. 2:36-44.
39. Scrima, A., and A. Wittinghofer. 2006. Dimerisation-dependent GTPase reaction of MnmE: how potassium acts as GTPase-activating element. EMBO J. 25:2940-2951.
40. Scrima, A., I. R. Vetter, M.-E. Armengod, and A. Wittinghofer. 2005. The structure of the TrmE GTP-binding protein and its implications for tRNA modification. EMBO J. 24:23-33.
41. Shepherd, R. K., N. Checcarelli, A. Naini, D. C. De Vivo, S. DiMauro, and C. M. Sue. 2006. Measurement of ATP production in mitochondrial disorders. J. Inherit. Metab. Dis. 29:86-91.
42. Smith, C. W. J., T. T. Chu, and B. Nadal-Ginard. 1993. Scanning and competition between AGs are involved in 3′ splice site selection in mammalian introns. Mol. Cell. Biol. 13:4939-4952.
43. Strausberg, R. L., E. A. Feingold, L. H. Grouse, J. G. Derge, R. D. Klausner, F. S. Collins, L. Wagner, C. M. Shenmen, G. D. Schuler, S. F. Altschul, et al. 2002. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 99:16899-16903.
44. Suzuki, T., T. Suzuki, T. Wada, K. Saigo, and K. Watanabe. 2002. Taurine as a constituent of mitochondrial tRNA: new insights into the functions of taurine and human mitochondrial diseases. EMBO J. 21:6581-6589.
45. Tian, B., J. Hu, H. Zhang, and C. Lutz. 2005. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 33:201-212.
46. Umeda, N., T. Suzuki, M. Yukawa, Y. Ohya, H. Shindo, K. Watanabe, and T. Suzuki. 2005. Mitochondria-specific RNA-modifying enzymes responsible for the biosynthesis of the wobble base in mitochondrial tRNAs. Implications for the molecular pathogenesis of human mitochondrial diseases. J. Biol. Chem. 280:1613-1624.
47. Vargas, J. L., F. Aniento, J. Cervera, and E. Knecht. 1989. Vanadate inhibits degradation of short-lived, but not of long-lived, proteins in L-132 human cells. Biochem. J. 258:33-40.
48. Yamanaka, K., J. Hwang, and M. Inouye. 2000. Characterization of GTPase activity of TrmE, a member of a novel GTPase superfamily, from Thermotoga maritime. J. Bacteriol. 182:7078-7082.
49. Yan, Q., X. Li, G. Faye, and M.-X. Guan. 2005. Mutations in MTO2 related to tRNA modification impair mitochondrial gene expression and protein synthesis in the presence of a paromomycin resistance mutation in mitochondrial 15 S rRNA. J. Biol. Chem. 280:29151-29157.
50. Yan, Q., Y. Bykhovskaya, R. Li, E. Mengesha, M. Shohat, X. Estivill, N. Fischel-Ghodsian, and M.-X. Guan. 2006. Human TRMU encoding the mitochondrial 5-methylaminomethyl-2-thiouridine-methyltransferase is a putative nuclear modifier gene for the phenotypic expression of the deafness-associated 12S rRNA mutations. Biochem. Biophys. Res. Commun. 342:1130-1136.
51. Yasukawa, T., Y. Kirino, N. Ishii, I. J. Holt, H. T. Jacobs, T. Makifuchi, N. Fukuhara, S. Ohta, T. Suzuki, and K. Watanabe. 2005. Wobble modification deficiency in mutant tRNAs in patients with mitochondrial diseases. FEBS Lett. 579:2948-2952.
52. Yasukawa, T., T. Suzuki, N. Ishii, S. Ohta, and K. Watanabe. 2001. Wobble modification defect in tRNA disturbs codon-anticodon interaction in a mitochondrial disease. EMBO J. 20:4794-4802.
53. Yasukawa, T., T. Suzuki, N. Ishii, Y. Ueda, S. Ohta, and K. Watanabe. 2000. Defect in modification at the anticodon wobble nucleotide of mitochondrial tRNALys with the MERRF encephalomyopathy pathogenic mutation. FEBS Lett. 467:175-178.
54. Yasukawa, T., T. Suzuki, S. Ohta, and K. Watanabe. 2002. Wobble modification defect suppresses translational activity of tRNAs with MERRF and MELAS mutations. Mitochondrion 2:129-141.
55. Leu(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J. Biol. Chem. 275:4251-4257.
56. Yim, L., I. Moukadiri, G. R. Björk, and M.-E. Armengod. 2006. Further insights into the tRNA modification process controlled by proteins MnmE and GidA of Escherichia coli. Nucleic Acids Res. 34:5892-5905.
57. Yim, L., M. Martínez-Vicente, M. Villarroya, C. Aguado, E. Knecht, and M.-E. Armengod. 2003. The GTPase activity and C-terminal cysteine of the Escherichia coli MnmE protein are essential for its tRNA modifying function. J. Biol. Chem. 278:28378-28387.